Similar companies
Income Statement (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 1.02B | 615.5% |
| Gross Profit | 809M | 3417.4% |
| Cost of Revenue | 207M | 73.9% |
| Operating expense | 1.07B | 14.9% |
| Net Income | -200M | 75.8% |
| EBITDA | -260M | 65.8% |
Balance Sheet (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 12.1B | 1% |
| Total Liabilities | 2.81B | 7.4% |
| Total Equity | 9.33B | 0.7% |
| Shares Outstanding | 390M | 0.5% |
Cash Flow (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | -847M | 7.8% |
| Cash from investing | 700M | 24.1% |
| Cash from financing | -1M | 111.1% |
EPS
Financial Highlights for Moderna in Q3 '25
Moderna reported a revenue of 1.02B, which is a 615.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 809M, marking a 3417.4% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 207M, a 73.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 1.07B, showing a 14.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -200M, showing a 75.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -260M, showing a 65.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Moderna with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
